We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc
ALPN

Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

58 hedge funds and large institutions have $55.4M invested in Alpine Immune Sciences Inc in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 11

2% less funds holding

Funds holding: 59 → 58 (-1)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

46% less capital invested

Capital invested by funds: $103M → $55.4M (-$48M)

Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
1.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
19
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$1.76M
2
SM
Sabby Management
Florida
+$793K
3
EAM
EverPoint Asset Management
Connecticut
+$626K
4
OM
Opaleye Management
Massachusetts
+$501K
5
BCM
Bridgeway Capital Management
Texas
+$375K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$1.75M
2
MCM
Marsico Capital Management
Colorado
-$1.06M
3
SFM
Sphera Funds Management
Israel
-$759K
4
KCM
Kingdon Capital Management
New York
-$716K
5
SIM
Spark Investment Management
New York
-$332K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
26
Ascend Capital
California
$208K +$250K +12,500 New
State Street
27
State Street
Massachusetts
$186K +$9.51K +475 +4%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$179K +$35.8K +1,787 +20%
RFC
29
Russell Frank Company
Washington
$134K +$95.8K +4,784 +147%
ECM
30
Endurant Capital Management
California
$129K – – –
RI
31
RTW Investments
New York
$125K – – –
Morgan Stanley
32
Morgan Stanley
New York
$119K +$139K +6,931 +3,165%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$97K +$47.9K +2,393 +71%
Goldman Sachs
34
Goldman Sachs
New York
$86K -$1.75M -87,298 -94%
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$84K +$101K +5,026 New
BIM
36
BlackRock Investment Management
Delaware
$67K +$1.72K +86 +2%
DCM
37
DAFNA Capital Management
California
$63K – – –
MFS
38
MSI Financial Services
Massachusetts
$63K +$50.1K +2,500 +200%
SIP
39
Stoneridge Investment Partners
Pennsylvania
$57K -$28.8K -1,439 -30%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$51K – – –
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$44K +$6.83K +341 +15%
TRCT
42
Tower Research Capital (TRC)
New York
$43K +$43.8K +2,187 +608%
NFA
43
Nationwide Fund Advisors
Ohio
$41K +$36K +1,800 +269%
TCIM
44
TIAA CREF Investment Management
New York
$35K – – –
TA
45
Teachers Advisors
New York
$20K – – –
Citigroup
46
Citigroup
New York
$18K +$20.8K +1,041 +20,820%
Barclays
47
Barclays
United Kingdom
$16K – – –
AIG
48
American International Group
New York
$12K +$14.4K +720 New
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$9K +$10.7K +532 New
Bank of America
50
Bank of America
North Carolina
$7K +$2.9K +145 +52%
1
2
3

ALPN Hedge Fund Activity: Q1 2016 in Review

58 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q1 2016, worth a combined $55.4M — down 46% from $103M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ALPN and 8 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 19 added.

The largest buyer was BVF Inc, adding an estimated $1.76M. The largest seller was Goldman Sachs, cutting an estimated $1.75M.

  • 58 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q1 2016, down from 59 in Q4 2015.
  • Funds reported $55.4M of Alpine Immune Sciences Inc stock for Q1 2016, down 46% quarter-over-quarter.
  • 8 funds opened new Alpine Immune Sciences Inc positions in Q1 2016 and 9 closed out, a net change of -1 holder.
  • The largest Alpine Immune Sciences Inc buyer in Q1 2016 was BVF Inc, an estimated $1.76M added.
  • The largest Alpine Immune Sciences Inc seller in Q1 2016 was Goldman Sachs, an estimated $1.75M sold.

Based on aggregated 13F filings for Q1 2016.